Scarica l'app Stockscreener
56.43
2.64%
-1.53
Pre-mercato:
56.31
-0.12
-0.21%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$57.96
Aprire:
$57.62
Volume 24 ore:
2.52M
Relative Volume:
0.71
Capitalizzazione di mercato:
$25.01B
Reddito:
$2.44B
Utile/perdita netta:
$1.36B
Rapporto P/E:
29.56
EPS:
1.9093
Flusso di cassa netto:
$574.14M
1 W Prestazione:
-2.32%
1M Prestazione:
+3.50%
6M Prestazione:
+40.48%
1 anno Prestazione:
+56.23%
Intervallo 1D:
$55.96
$57.98
Intervallo di 1 settimana:
$55.96
$58.84
Portata 52W:
$34.08
$58.84
Royalty Pharma Plc Stock (RPRX) Company Profile
Nome
Royalty Pharma Plc
Settore
Industria
Telefono
(212) 883-0200
Indirizzo
110 EAST 59TH STREET, NEW YORK, NY
Compare RPRX vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
56.43 | 25.01B | 2.44B | 1.36B | 574.14M | 1.9093 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-30 | Aggiornamento | UBS | Neutral → Buy |
| 2025-09-30 | Iniziato | Goldman | Buy |
| 2025-05-16 | Iniziato | Morgan Stanley | Overweight |
| 2024-06-03 | Downgrade | UBS | Buy → Neutral |
| 2022-06-14 | Ripresa | UBS | Buy |
| 2022-05-13 | Iniziato | Scotiabank | Sector Outperform |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-29 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-30 | Iniziato | Tigress Financial | Buy |
| 2020-11-09 | Aggiornamento | UBS | Neutral → Buy |
| 2020-07-14 | Iniziato | Evercore ISI | In-line |
| 2020-07-13 | Iniziato | BofA Securities | Buy |
| 2020-07-13 | Iniziato | Citigroup | Neutral |
| 2020-07-13 | Iniziato | Cowen | Outperform |
| 2020-07-13 | Iniziato | Goldman | Neutral |
| 2020-07-13 | Iniziato | JP Morgan | Neutral |
| 2020-07-13 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Iniziato | SunTrust | Buy |
| 2020-07-13 | Iniziato | UBS | Neutral |
Mostra tutto
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Royalty Pharma Q1 2026 earnings preview - MSN
World Investment Advisors Sells 48,485 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX is Torray Investment Partners LLC's Largest Position - MarketBeat
Hsbc Holdings PLC Lowers Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX) Citi Annual Global Healthcare Conference 2025 Summary - Quartr
Why Royalty Pharma (RPRX) Could Beat Earnings Estimates Again - Yahoo Finance Singapore
Are You Looking for a Top Momentum Pick? Why Royalty Pharma (RPRX) is a Great Choice - Yahoo! Finance Canada
Royalty Pharma PLC (RPRX) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Russell 1000 Defensive Inclusion Might Change The Case For Investing In Royalty Pharma (RPRX) - Sahm
How (RPRX) Movements Inform Risk Allocation Models - Stock Traders Daily
RPRX or ACAD: Which Is the Better Value Stock Right Now? - Yahoo Finance
Teva Reports Early Skin Repigmentation Data, Sets Stage For Next Trial - Sahm
Royalty Pharma (RPRX) 7th Annual Evercore ISI HealthCONx Healthcare Conference summary - Quartr
Y Intercept Hong Kong Ltd Grows Stake in Royalty Pharma PLC $RPRX - MarketBeat
Swedbank AB Sells 355,450 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma stock hits all-time high at 58.02 USD - Investing.com
Royalty Pharma stock hits all-time high at 58.02 USD By Investing.com - Investing.com Nigeria
Royalty Pharma plc (RPRX) Stock Analysis: Navigating the Biotech Sector with Robust Revenue Growth - DirectorsTalk Interviews
Royalty Pharma PLC $RPRX Shares Sold by Inspire Investing LLC - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Boosts Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Fideuram Intesa Sanpaolo Private Banking S.P.A. Has $439,000 Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC (NASDAQ:RPRX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Moran Wealth Management LLC Boosts Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC (RPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ETFs Investing in Royalty Pharma Plc Class A Stocks - TradingView
USS Investment Management Ltd Boosts Position in Royalty Pharma PLC $RPRX - MarketBeat
Pictet Asset Management Holding SA Increases Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (NASDAQ:RPRX) EVP Sells $5,652,000.00 in Stock - MarketBeat
[Form 4] Royalty Pharma plc Insider Trading Activity - Stock Titan
Royalty Pharma (RPRX) EVP Hite sells 130,000 shares in 10b5-1 trades - Stock Titan
Royalty Pharma plc (RPRX) insider Marshall Urist reports sales totaling ~$1.95M - Stock Titan
Form 144 Royalty Pharma PLC For: 1 July By Investing.com - Investing.com South Africa
[144] Royalty Pharma plc SEC Filing - Stock Titan
Royalty Pharma (RPRX) Shares Rally Following Earnings Report That Beat EstimatesTech Earnings Analysis - dars.gov.et
Form 4 Royalty Pharma Plc For: 30 June By Investing.com - Investing.com South Africa
Royalty Pharma (RPRX) director gets equity grant in lieu of cash - Stock Titan
Hsbc Holdings PLC Cuts Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Hits New 12-Month HighTime to Buy? - MarketBeat
Royalty Pharma stock hits all-time high at 56.57 USD By Investing.com - Investing.com Nigeria
Royalty Pharma stock hits all-time high at 56.57 USD - Investing.com
Royalty Pharma, plc (RPRX) Rallied on Earnings Beat - Insider Monkey
Royalty Pharma (RPRX) Stock Analysis: Evaluating Its 5.37% Potential Upside and Strong Buy Ratings - DirectorsTalk Interviews
Rockefeller Capital Management L.P. Purchases 81,747 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Does Royalty Pharma’s (RPRX) Index Upgrade Signal Deeper Defensive Strength In Its Business Model? - simplywall.st
Royalty Pharma plc(NasdaqGS: RPRX) added to Russell 1000 Value-Defensive Index - marketscreener.com
Enterprise value to revenue forward of Royalty Pharma plc – NASDAQ:RPRX - TradingView
Trading Systems Reacting to (RPRX) Volatility - Stock Traders Daily
Royalty Pharma PLC $RPRX Shares Sold by Goodman Advisory Group LLC - MarketBeat
Enterprise value to EBITDA forward of Royalty Pharma plc – NASDAQ:RPRX - TradingView
Enterprise value to EBIT forward of Royalty Pharma plc – NASDAQ:RPRX - TradingView
Price to earnings forward of Royalty Pharma plc – NASDAQ:RPRX - TradingView
Royalty Pharma Plc Azioni (RPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):